179 related articles for article (PubMed ID: 4380581)
1. [Preliminary results with antimetabolite therapy of autoaggressive diseases in dermatology].
Schirren CG
Munch Med Wochenschr; 1965 Dec; 107(50):2553-7. PubMed ID: 4380581
[No Abstract] [Full Text] [Related]
2. [Immunosuppressive agents in dermatology].
Schuppli R
Dtsch Med Wochenschr; 1970 Dec; 95(51):2576-7. PubMed ID: 5513651
[No Abstract] [Full Text] [Related]
3. [Use of antimetabolites in diseases of auto-aggression].
Romiti N
Hospital (Rio J); 1968 Jan; 73(1):71-8. PubMed ID: 5308511
[No Abstract] [Full Text] [Related]
4. [Indications and limits of long-term therapy with immunosuppressive (and cytostatic) agents in various chronic skin diseases].
Schulze P
Z Arztl Fortbild (Jena); 1977 Jun; 71(12):562-4. PubMed ID: 20701
[No Abstract] [Full Text] [Related]
5. [Immunosuppressive agents for therapy of autoimmune diseases of the skin and of psoriasis].
Ruszczak Z
Hautarzt; 1977 Mar; 28(3):125-31. PubMed ID: 15957
[TBL] [Abstract][Full Text] [Related]
6. The management of lupus erythematosus, scleroderma, lichen sclerosus and dermatomyositis.
Rowell NR
Clin Exp Dermatol; 1982 Jul; 7(4):407-14. PubMed ID: 7127889
[No Abstract] [Full Text] [Related]
7. Immunosuppressive therapy. 1.
Skinner MD; Schwartz RS
N Engl J Med; 1972 Aug; 287(5):221-7. PubMed ID: 4556641
[No Abstract] [Full Text] [Related]
8. [Complications of immunosuppressive therapy using cytostatics in autoaggression diseases with special reference to cholestatic hepatosis].
Götzel L
Z Gesamte Inn Med; 1973 Jun; 28(11):331-5. PubMed ID: 4146995
[No Abstract] [Full Text] [Related]
9. [Immunosuppressive therapy of collagenoses].
Miescher PA
Verh Dtsch Ges Inn Med; 1972; 78():774-7. PubMed ID: 4146711
[No Abstract] [Full Text] [Related]
10. [On some essential differences of scleroderma, dermatomyositis and acute lupus erythematosus and the variegated therapy based on them].
Korting GW
Dtsch Med Wochenschr; 1967 Feb; 92(7):281-8. PubMed ID: 6019059
[No Abstract] [Full Text] [Related]
11. [Rheumatic and pararheumatic diseases. Problems of diagnosis and therapy].
Scheiffarth F
Fortschr Med; 1973 Jul; 91(20):859-62. PubMed ID: 4146346
[No Abstract] [Full Text] [Related]
12. Treatment of the diseases of the dermis.
Polano MK
Arch Belg Dermatol Syphiligr; 1972; 28(1):59-73. PubMed ID: 4656306
[No Abstract] [Full Text] [Related]
13. The dermatological aspects of collagen diseases.
STORCK H
Int Arch Allergy Appl Immunol; 1963; 22():205-35. PubMed ID: 13984418
[No Abstract] [Full Text] [Related]
14. [Treatment of collagen diseases].
CARCASSONNE Y
Mars Med; 1963; 100():385-90. PubMed ID: 14018579
[No Abstract] [Full Text] [Related]
15. [Experiences with long-term immunosuppressive therapy of connnective tissue diseases].
Apostoloff E; Reitzig P; Jendrusch C; Apostoloff G
Z Gesamte Inn Med; 1974 Jan; 29(1):26-30. PubMed ID: 4820047
[No Abstract] [Full Text] [Related]
16. [Creatine metabolism disorders in dermatomyositis, progressive scleroderma, visceral and cutaneous lupus erythematosus and panarteritis bodosa].
Kreysel H; Jänner M; Wehrmann R
Hautarzt; 1968 Sep; 19(9):422-8. PubMed ID: 4386570
[No Abstract] [Full Text] [Related]
17. Immunosuppressive therapy in rheumatic disease.
Pirofsky B; Bardana EJ
Med Clin North Am; 1977 Mar; 61(2):419-37. PubMed ID: 16187
[No Abstract] [Full Text] [Related]
18. The clinical effects of cortisone and ACTH (adrenocorticotropic hormone) in the collagen diseases: acute disseminated lupus erythematosus, periarteritis nodosa, dermatomyositis and scleroderma; interim report.
OGRYZLO MA
Treat Serv Bull; 1952; 7(7):311-2. PubMed ID: 12984521
[No Abstract] [Full Text] [Related]
19. The use of corticosteroid agents in connective tissue disorders.
Barraclough D
Med J Aust; 1986 Apr; 144(8):427-32. PubMed ID: 2870416
[No Abstract] [Full Text] [Related]
20. [Advantages and disadvantages of steroid therapy in skin diseases].
Steigleder GK
Klin Monbl Augenheilkd; 1966; 148(6):800-10. PubMed ID: 5987288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
